Price by Quantity
Keytruda (Pembrolizumab) is an immunotherapy medication used to treat various types of cancer, including melanoma, lung cancer, and others. It works by enhancing the body’s immune system to detect and fight cancer cells more effectively.
Disclaimer:This medication must be administered under oncologist supervision. It may cause immune-related side effects affecting organs such as lungs, liver, or intestines. Immediate medical attention is required if serious reactions occur.
| Minimum Order | 10 |
| Brand Name | Keytruda |
| Strength | 100 Mg / 4 ML |
| Pharmacological Class | PD-1 Inhibitor |
| Generic Name | Pembrolizumab |
| Dosage Form | Injection |
| Mechanism | Blocks PD-1 Receptor |
| Dosing Frequency | Every 3– 6 Weeks |
| Bioavailability | IV (100%) |
| Route | Intravenous |
| Solution PH | Approximately 5.2 To 5.8 |
| Prescription Status | Prescription Only |
| Common Side Effects | Fatigue, Rash |
| Contraindications | Severe Immune Reactions |
| Approval | FDA Approved |
| Preparation Use | Dilution Required |
| Storage (Unopened) | Must Be Refrigerated 2°C |
| Indications | Multiple Cancers |
| Manufacture By | Health Point Pharmacy |
